News

Filter

Current filters:

Eli Lilly

201 to 210 of 96906 results

New analysis of potential savings from Biosimilars in USA

New analysis of potential savings from Biosimilars in USA

04-11-2014

Introducing competing “biosimilar” versions of complex biologic drugs used to treat illnesses such…

Anti-Arthritics/RheumaticsBiosimilarsFinancialGenericsOncologyRegulationSandozUSA

AstraZeneca, Pharmacyclics and Janssen team up on Imbruvica and MEDI4736 combination trial

AstraZeneca, Pharmacyclics and Janssen team up on Imbruvica and MEDI4736 combination trial

04-11-2014

Anglo-Swedish drug major AstraZeneca and US health care giant Johnson & Johnson’s Europe-based subsidiary…

AstraZenecaBiotechnologyImbruvicaJanssenMEDI4736OncologyPharmacyclicsResearchUK

Sanofi reports positive data in Phase III dengue vaccine trial, with 95.5% efficacy against severe dengue

Sanofi reports positive data in Phase III dengue vaccine trial, with 95.5% efficacy against severe dengue

04-11-2014

French drug major Sanofi has reported positive data with its experimental tetravalent dengue vaccine…

Anti-viralsFrancePharmaceuticalResearchSanofi Pasteur

AstraZeneca and University of Glasgow partner to form immunology discovery center

AstraZeneca and University of Glasgow partner to form immunology discovery center

04-11-2014

The University of Glasgow and Anglo-Swedish drug major AstraZeneca have now officially launched the GLAZgo…

AstraZenecaImmunologicalsPharmaceuticalResearchUK

Abilify Maintena shows superior efficacy to paliperidone palmitate

Abilify Maintena shows superior efficacy to paliperidone palmitate

04-11-2014

Danish CNS specialist Lundbeck and the US subsidiary of Japan’s Otsuka Pharmaceutical have released…

Abilify MaintenaLundbeckNeurologicalOtsuka Pharmaceuticalpaliperidone palmitatePharmaceuticalResearch

UK's NICE recommends GSK's Arzerra for untreated chronic lymphocytic leukemia

UK's NICE recommends GSK's Arzerra for untreated chronic lymphocytic leukemia

04-11-2014

The UK’s National Institute for Health and Care Excellence has issued new preliminary draft guidance…

ArzerraGSKOfatumumab InjectionOncologyPharmaceuticalRegulationUK

Bristol-Myers enters option agreement to acquire Danish firm

Bristol-Myers enters option agreement to acquire Danish firm

03-11-2014

US pharma major Bristol-Myers Squibb has entered into an exclusive option agreement to buy Denmark-based…

BiotechnologyBristol-Myers SquibbGalecto BiotechMergers & AcquisitionsRespiratory and PulmonaryTD139

Nymox plunges as NX1207 fails Ph III endpoints

03-11-2014

Canada-based biotech firm Nymox Pharmaceutical saw its shares decimated in pre-market trading after it…

BiotechnologyMen's HealthNX1207Nymox PharmaRecordatiResearch

201 to 210 of 96906 results

Back to top